| Page | |
|---|---|
| Balance Sheet | 1—2 |
| Notes to the Financial Statements | 3—10 |
| 2024 | 2023 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ | £ | £ | |
| FIXED ASSETS | |||||
| Tangible Assets | 4 |
|
|
||
|
|
|
||||
| CURRENT ASSETS | |||||
| Debtors | 6 |
|
|
||
| Cash at bank and in hand |
|
|
|||
|
|
|
||||
| Creditors: Amounts Falling Due Within One Year | 7 |
( |
( |
||
| NET CURRENT ASSETS (LIABILITIES) |
( |
( |
|||
| TOTAL ASSETS LESS CURRENT LIABILITIES |
( |
( |
|||
| NET LIABILITIES |
( |
( |
|||
| CAPITAL AND RESERVES | |||||
| Called up share capital | 8 |
|
|
||
| Share premium account |
|
|
|||
| Share based payment reserve |
|
|
|||
| Profit and Loss Account |
( |
( |
|||
| SHAREHOLDERS' FUNDS | (44,133,231) | (35,631,229) | |||
|
Director
|
| Office equipment |
|
| Office equipment | |
|---|---|
| £ | |
| Cost | |
| As at 1 January 2024 |
|
| Disposals |
( |
| As at 31 December 2024 |
|
| Depreciation | |
| As at 1 January 2024 |
|
| Provided during the period |
|
| Disposals |
( |
| As at 31 December 2024 |
|
| Net Book Value | |
| As at 31 December 2024 |
|
| As at 1 January 2024 |
|
| Subsidiaries | |
|---|---|
| £ | |
| Cost | |
| As at 1 January 2024 |
|
| As at 31 December 2024 |
|
| Provision | |
| As at 1 January 2024 |
|
| As at 31 December 2024 |
|
| Net Book Value | |
| As at 31 December 2024 |
|
| As at 1 January 2024 |
|
|
Subsidiary undertakings
|
Registered office
|
Class of share
|
%
|
|
ASD Therapeutics LLC
|
1209 Orange Street, Delaware, 19801
|
Ordinary
|
100
|
|
AMO Pharma Services Corporation
|
1209 Orange Street, Delaware, 19801
|
Ordinary
|
100
|
|
AMO-01 Pharma Limited
|
Burnham House, Splash Lane, Wyton, Huntingdon, Cambridgeshire, PE28 2AF
|
Ordinary
|
100
|
|
AMO-06 Pharma Limited
|
Burnham House, Splash Lane, Wyton, Huntingdon, Cambridgeshire, PE28 2AF
|
Ordinary
|
100
|
| 2024 | 2023 | ||
|---|---|---|---|
| £ | £ | ||
| Due within one year | |||
| Amounts owed by group undertakings | 1,266 | 1,266 | |
| Other debtors | 2,540,431 | 4,388,349 | |
|
|
|
||
| 2024 | 2023 | ||
|---|---|---|---|
| £ | £ | ||
| Trade creditors |
|
|
|
| Financial liabilities (note 11) |
|
|
|
| Amounts owed to group undertakings |
|
|
|
| Other creditors | 1,992,704 | 1,651,106 | |
| Taxation and social security |
|
|
|
|
|
|
||
|
2024
|
2023
|
||
|
Financial liabilities measured at fair value through profit or loss
|
£
|
£
|
|
|
Bridging loan
|
14,930,072
|
9,828,040
|
|
|
Redeemable preference shares
|
27,855,919
|
27,380,729
|
|
|
42,785,991
|
37,208,769
|